We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+12.34%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$3.17B
AUM Growth
+$261M
Cap. Flow
-$2.24M
Cap. Flow %
-0.07%
Top 10 Hldgs %
21.23%
Holding
3,406
New
272
Increased
638
Reduced
833
Closed
208

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$7.7M
2
SHOP icon
Shopify
SHOP
+$3.98M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$3.8M
4
OKTA icon
Okta
OKTA
+$3.47M
5
APG icon
APi Group
APG
+$3.04M

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.99M
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$3.67M
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.86M
4
BERY
Berry Global Group, Inc.
BERY
+$2.11M
5
X
US Steel
X
+$1.87M

Sector Composition

Rank Sector Weight
1 Technology 23.69%
2 Industrials 9.96%
3 Financials 9.71%
4 Consumer Discretionary 9.41%
5 Healthcare 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPSC icon
3251
Century Therapeutics
IPSC
$353M
– –
-905
Closed -$431
IRBT
3252
DELISTED
iRobot
IRBT
– –
-2,726
Closed -$7.36K
IVVD icon
3253
Invivyd
IVVD
$216M
– –
-7,770
Closed -$4.7K
JSPR icon
3254
Jasper Therapeutics
JSPR
$27.4M
– –
-1,109
Closed -$4.77K
JWN
3255
DELISTED
Nordstrom
JWN
– –
-19,160
Closed -$468K
KNSA icon
3256
Kiniksa Pharmaceuticals
KNSA
$6.1B
– –
-3,649
Closed -$81K
LCTX icon
3257
Lineage Cell Therapeutics
LCTX
$278M
– –
-10,656
Closed -$4.81K
LCUT icon
3258
Lifetime Brands
LCUT
$219M
– –
-1,219
Closed -$6.01K
LESL icon
3259
Leslie's
LESL
$12.4M
– –
-883
Closed -$13K
LNZA icon
3260
LanzaTech
LNZA
$67.1M
– –
-110
Closed -$2.65K
LSEA
3261
DELISTED
Landsea Homes
LSEA
– –
-2,092
Closed -$13.4K
LVO icon
3262
LiveOne
LVO
$55.5M
– –
-667
Closed -$4.66K
LWLG icon
3263
Lightwave Logic
LWLG
$1.23B
– –
-11,312
Closed -$11.6K
LXRX icon
3264
Lexicon Pharmaceuticals
LXRX
$1.05B
– –
-8,867
Closed -$4.09K
LYEL icon
3265
Lyell Immunopharma
LYEL
$347M
– –
-856
Closed -$9.21K
LYRA
3266
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-95
Closed -$599
MDB icon
3267
MongoDB
MDB
$35.2B
– –
-2,438
Closed -$428K
METCB icon
3268
Ramaco Resources Class B
METCB
$416M
– –
-429
Closed -$2.89K
MGNX icon
3269
MacroGenics
MGNX
$256M
– –
-6,300
Closed -$8K
MODV
3270
DELISTED
ModivCare
MODV
– –
-1,257
Closed -$1.65K
MRAM icon
3271
Everspin Technologies
MRAM
$415M
– –
-1,907
Closed -$9.73K
MRSN
3272
DELISTED
Mersana Therapeutics
MRSN
– –
-396
Closed -$3.41K
NAUT icon
3273
Nautilus Biotechnolgy
NAUT
$114M
– –
-3,575
Closed -$3.08K
NKTR icon
3274
Nektar Therapeutics
NKTR
$2.57B
– –
-1,166
Closed -$11.9K
NMRA icon
3275
Neumora Therapeutics
NMRA
$317M
– –
-8,241
Closed -$8.24K
129 130
131
132 133

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Ameritas Investment Partners held 3,406 positions worth $3.17B, up 9% from $2.91B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2025 filing shows 272 new, 638 increased, 833 reduced and 208 closed positions. Its largest new stake was Okta: 32,456 shares worth $3.24M. The largest sale was Vanguard S&P 500 ETF, an estimated $4.99M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Ameritas Investment Partners's largest Q2 2025 buy was Okta: 32,456 shares worth $3.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q2 2025, an estimated $7.7M increase.
  • Ameritas Investment Partners's biggest Q2 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.99M.
  • Ameritas Investment Partners fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $2.11M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $3.17B portfolio in Q2 2025.
  • Ameritas Investment Partners opened 272 new positions and closed 208 in Q2 2025.
  • Ameritas Investment Partners's portfolio value rose 9% quarter-over-quarter to $3.17B.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.